TCON — TRACON Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $0.15m
- -$6.12m
- $12.05m
Brief: TRACON Pharmaceuticals Initiates Phase 2 Trial Of TRC102 In Lung Cancer
U.S. STOCKS ON THE MOVE-regular hours
U.S. STOCKS ON THE MOVE-GoDaddy, Nvidia, travel stocks
Brief: Tracon Pharmaceuticals Announces Results From Review Of Interim Safety And Efficacy Data From Envasarc Pivotal Trial
Brief: Tracon Pharmaceuticals Reports Regulatory Approval Of Envafolimab In China
Brief: Tracon Pharmaceuticals Q3 Net Loss $7 Mln
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In September: Earnings Summary
Tracon Pharmaceuticals Inc Expected To Post A Loss Of 32 Cents A Share: Earnings Preview
Brief: TRACON Pharmaceuticals Inc And Eucure BiopharmaAnnounce Partnership For Development Of Clinical Stage CTLA-4 Antibody YH001
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In June: Earnings Summary
Brief: Tracon Pharmaceuticals Posts Quarterly Loss Per Share Of $0.58
Tracon Pharmaceuticals Inc Expected To Post A Loss Of 31 Cents A Share: Earnings Preview
Brief: Tracon Pharmaceuticals Announces Results Of Second Independent Data Monitoring Committee Review Of Safety Data From Envasarc Pivotal Trial
Brief: Tracon Pharmaceuticals Inc - Entered Amended And Restated Underwriting Agreement With H.C. Wainwright & Co., Llc
U.S. STOCKS ON THE MOVE-Sequential Brands, Summit Wireless, Seres Therapeutics
U.S. STOCKS ON THE MOVE-Seres Therapeutics, TRACON Pharmaceuticals, NeuroMetrix
U.S. STOCKS ON THE MOVE-Crocs, NeuroMetrix, Seres Therapeutics
Tracon Pharma Drops On Deep: discounted stock deal
Brief: Tracon Pharmaceuticals Increases Previously Announced Bought Deal Offering Of Common Stock To $15 Mln